EHR Vendors Control Clinical AI

Control of the EHR is control of AI distribution in healthcare. Once an AI tool moves from a browser tab into the patient chart, the EHR vendor decides who gets embedded access, how deep the workflow goes, and how economics are split. That is why Epic, Oracle Health, and Microsoft have a strong incentive to own the clinical AI layer themselves, instead of letting OpenEvidence become the default interface inside the chart.

• Epic is already shipping its own native AI. In February 2026 it rolled out AI Charting inside Epic, which listens during visits, drafts notes, and queues orders. Epic also says its clinician summary product is used more than 16 million times per month. That makes third party copilots fight against a built in workflow, not a blank slate.
  2 epic 3 epic
• Microsoft has become the obvious partner for EHR vendors that do not want to build every model layer themselves. Dragon Copilot is embedded in supported EHRs including Epic, with mobile support in Epic Rover for nurses. In practice, that gives hospitals a way to buy AI from an incumbent they already trust for speech, cloud, security, and enterprise contracting.
  4 microsoft 5 microsoft 6 microsoft
• The closest comparable is Abridge. It won deep Epic access, but that came with tight alignment, including equity and revenue share, and limited freedom to compete directly with Epic. That shows the likely shape of OpenEvidence's path inside EHRs, preferred distribution is possible, but usually on terms that favor the platform owner.
  7 sacra 8 sacra 9 sacra

Going forward, clinical AI will look less like an open app market and more like a controlled layer inside a few dominant record systems. OpenEvidence can still win, but the winning version is likely one that fits inside Epic or Oracle workflows, or complements Microsoft and Nuance, rather than trying to sit above them as an independent destination.